[1]
C. Simioni, S. Ultimo, A. M. Martelli, G. Zauli, S. Capitani, and L. M. Neri, “Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway and NUP214-ABL1 fusion protein in human acute lymphoblastic leukemia”, Ital J Anat Embryol, vol. 121, no. 1, p. 127, Oct. 2017.